Company
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Suzhou Suncadia Biopharmaceuticals Co., Ltd. has 2 drugs tracked on RxWires: 1 in Phase 3, 1 in Phase 2/3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| SHR-A2009 + bevacizumab | Phase 3 | Non-squamous Non-small Cell Lung Cancer |
| SHR-A2102 | Phase 2/3 | Muscular Invasive Bladder Cancer (MIBC) |
Latest
No recent events.
Follow Suzhou Suncadia Biopharmaceuticals Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.